A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection (GS-US-248-0123)

Trial ID:
IRB-11-5848
Paul Pockros
This Registry is designed to obtain long term data on subject who have failed to achieve sustained virologic response (SVR) while receiving at leas

Inclusion Criteria:

  • Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV;
  • Have failed to achieve an SVR in a previous Gilead-sponsored study, as defined in the original treatment protocol;
  • Provide written, informed consent
  • Be willing and able to comply with the visit schedule.

Exclusion Criteria:

  • Subject plans to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry.
  • History of clinically-significant illness or any other major medical disorder that may interfere with subject follow-up, assessments or compliance with the protocol.